348 related articles for article (PubMed ID: 25776551)
1. Effectiveness of core biopsy for screen-detected breast lesions under 10 mm: implications for surgical management.
Farshid G; Downey P; Pieterse S; Gill PG
ANZ J Surg; 2017 Sep; 87(9):725-731. PubMed ID: 25776551
[TBL] [Abstract][Full Text] [Related]
2. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques.
Gisvold JJ; Goellner JR; Grant CS; Donohue JH; Sykes MW; Karsell PR; Coffey SL; Jung SH
AJR Am J Roentgenol; 1994 Apr; 162(4):815-20. PubMed ID: 8140997
[TBL] [Abstract][Full Text] [Related]
3. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
Carder PJ; Liston JC
J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional targeting: a new three-dimensional ultrasound technique to evaluate needle position during breast biopsy.
Weismann CF; Forstner R; Prokop E; Rettenbacher T
Ultrasound Obstet Gynecol; 2000 Sep; 16(4):359-64. PubMed ID: 11169313
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique.
Seoudi H; Mortier J; Basile R; Curletti E
Arch Surg; 1998 Apr; 133(4):366-72. PubMed ID: 9565115
[TBL] [Abstract][Full Text] [Related]
7. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy.
Zuiani C; Londero V; Bestagno A; Puglisi F; Di Loreto C; Bazzocchi M
Radiol Med; 2005; 110(5-6):589-602. PubMed ID: 16437044
[TBL] [Abstract][Full Text] [Related]
8. Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data.
Farshid G; Downey P; Gill P; Pieterse S
Br J Cancer; 2008 Apr; 98(7):1182-90. PubMed ID: 18382460
[TBL] [Abstract][Full Text] [Related]
9. Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis).
Rakha EA; El-Sayed ME; Reed J; Lee AHS; Evans AJ; Ellis IO
Eur J Cancer; 2009 May; 45(7):1162-1167. PubMed ID: 19121932
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
[TBL] [Abstract][Full Text] [Related]
11. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
Lee AH; Denley HE; Pinder SE; Ellis IO; Elston CW; Vujovic P; Macmillan RD; Evans AJ;
Histopathology; 2003 Apr; 42(4):331-6. PubMed ID: 12653944
[TBL] [Abstract][Full Text] [Related]
12. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.
Mikhail RA; Nathan RC; Weiss M; Tummala RM; Mullangi UR; Lawrence L; Mukkamala A
Ann Surg Oncol; 1994 Sep; 1(5):363-7. PubMed ID: 7850536
[TBL] [Abstract][Full Text] [Related]
14. The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications: analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program.
Farshid G; Rush G
Cancer; 2003 Dec; 99(6):357-64. PubMed ID: 14681944
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
[TBL] [Abstract][Full Text] [Related]
16. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy.
Brenner RJ; Fajardo L; Fisher PR; Dershaw DD; Evans WP; Bassett L; Feig S; Mendelson E; Jackson V; Margolin FR
AJR Am J Roentgenol; 1996 Feb; 166(2):341-6. PubMed ID: 8553943
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities.
Symmans WF; Weg N; Gross J; Cangiarella JF; Tata M; Mazzo JA; Waisman J
Cancer; 1999 Mar; 85(5):1119-32. PubMed ID: 10091797
[TBL] [Abstract][Full Text] [Related]
20. [Stereotactic core needle biopsy for diagnosis of mammographic minimal lesions].
Ge LY; Huan Q; Liu XJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 35(5):551-4. PubMed ID: 17063551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
